GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

359 papers

Showing 253-264 of total 359 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Antidepressant effects of facial botulinum toxin a injections: Insights from randomized controlled trials.

Gao Z; Chen X; Yu X; Hu L; Gao C

Jan 1, 2026Journal of affective disorders

2026PubMedSupporting evidence

Early surgery vs. conservative management for traumatic intracerebral hematoma: A systematic review and Bayesian meta-analysis.

Penchev P; Milanova-Ilieva D; Gaydarski L; Reghunathan K; Alonso-Vera JE; Grigorov G; Petrov PP; Stanchev P; Noack L; Ramadanov N

Jan 1, 2026Brain & spine

2026PubMedSupporting evidence

Comparative Efficacy of Herbal Products on Metabolic Parameters in Metabolic-Dysfunction Associated Liver Disease: A Systematic Review and Network Meta-Analysis.

Sairaj RT; Chen Liang A; Cruz Castillo Y; Fermin Madera MD; Medina J; Moreno Díaz TA; Flores Monar G; Chintamaneni S; Sanchez Cruz C; Advani R; Guha S; Calderón-Martinez E

Jan 1, 2026Gastro hep advances

2026PubMedSupporting evidence

Successful Reversal of Tamoxifen-Associated Weight Gain and Metabolic Dysfunction with Liraglutide in a Breast Cancer Survivor: A Case Report.

Anvarbek M; Umarov D; Khalbayeva Z; Smerat A; Adi M; Ashraf A

Jan 1, 2026Clinical medicine insights. Case reports

2026PubMedDirectly related

For Weight Loss: Why Do GLP-1 Agonists Work, and How Can We Make Them Work Better?

Giang C; Meng J; Mohammad MA; Liu Z; Wu X; Zhu Y

Jan 1, 2026Biology

2026PubMedDirectly related

Do Patients Receiving GLP-1 Receptor Agonists for Weight Loss Require Structured Dietetic Care? Lessons from Metabolic and Bariatric Surgery (MBS) Pathways.

Balasubaramaniam V; Scobie M; O'Kane M; Graham Y; Robertson AG; Mahawar K

Jan 1, 2026Nutrients

2026PubMedDirectly related

Beyond Weight Loss: Skeletal Muscle Health During Incretin-Based Therapy in Patients with Diabesity.

Mollero ELM; Dozzani I; Biamonte E; Bendotti G; Marzullo P; Aimaretti G; Gallo M

Jan 1, 2026Nutrients

2026PubMedSupporting evidence

GLP-1 Receptor Agonists in Obstructive Sleep Apnea: A Translational Perspective on Mechanisms and Clinical Implications.

Gómez-Maldonado I; Rodríguez-Arana A; Tamayo-Pinzón A; Albornoz-Suárez JE; López-Franco MJ; Mejia-Manrique JA; Forero-Caycedo JJ; Rojas-Rodríguez LC; Buitrago-Ricaurte N; Gaviria-Carrillo M; Rodríguez-Quintana J; Calderón-Ospina CA

Jan 1, 2026International journal of molecular sciences

2026PubMedDirectly related

Effects of Incretin-Based Therapies on Testosterone Levels and Incretin Response in Men with Hypogonadism: A Systematic Literature Review Following PRISMA 2020 Guidelines.

La Vignera S; Condorelli R

Jan 1, 2026Pharmaceuticals (Basel, Switzerland)

2026PubMedDirectly related

From adiposity to multisystem morbidity: the case for weight loss as disease modification.

Sattar N; Ferguson LD; Lee MMY

Jan 1, 2026The lancet. Diabetes & endocrinology

2026PubMedDirectly related

Therapeutic Potential of Anti-Obesity Drugs in Obesity-Associated Female Reproductive Dysfunction: Translating Mechanistic Evidence into Personalized Clinical Strategies.

Varra FN; Theodosis-Nobelos P; Varra VK; Varras M

Jan 1, 2026Medicina (Kaunas, Lithuania)

2026PubMedDirectly related

Weight Recurrence After Bariatric Surgery: Incretin-Based Therapies and the Evolving Role of Revisional Surgery.

Huerta Díaz LA; Lopez Alanis BA; Zorrilla-Nuñez LF; Muñoz-Maldonado GE

Jan 1, 2026Cureus